dolutegravir

cytochrome P450 family 3 subfamily A member 4 ; Homo sapiens







10 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34328253 In vitro assessment of the potential for dolutegravir to affect hepatic clearance of levonorgestrel. 2021 Nov 3
2 34909672 Pharmacokinetic drug interactions of integrase strand transfer inhibitors. 2021 1
3 32011683 Genetic influence of ABCG2, UGT1A1 and NR1I2 on dolutegravir plasma pharmacokinetics. 2020 May 1 2
4 28915895 Impact of UGT1A1 gene polymorphisms on plasma dolutegravir trough concentrations and neuropsychiatric adverse events in Japanese individuals infected with HIV-1. 2017 Sep 16 4
5 26898568 Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation. 2016 Jun 2
6 25733917 The role of dolutegravir in the management of HIV infection. 2015 1
7 25845873 Pharmacokinetics of dolutegravir in a premature neonate after HIV treatment intensification during pregnancy. 2015 1
8 25858605 [Mechanisms of action, pharmacology and interactions of dolutegravir]. 2015 Mar 1
9 24096683 Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment. 2014 Jan 2
10 23824675 Clinical pharmacokinetic, pharmacodynamic and drug-interaction profile of the integrase inhibitor dolutegravir. 2013 Nov 1